Philip Masson1, Patrick J Kelly2, Jonathan C Craig3, Richard I Lindley4, Angela C Webster5. 1. Sydney School of Public Health and Centre for Kidney Research, Children's Hospital at Westmead, Westmead, New South Wales, Australia; and philip.masson@sydney.edu.au. 2. Sydney School of Public Health and. 3. Sydney School of Public Health and Centre for Kidney Research, Children's Hospital at Westmead, Westmead, New South Wales, Australia; and. 4. The George Institute for Global Health, University of Sydney, Sydney, New South Wales, Australia; 5. Sydney School of Public Health and Centre for Kidney Research, Children's Hospital at Westmead, Westmead, New South Wales, Australia; and Centre for Renal and Transplant Research, Westmead Hospital, Westmead, New South Wales, Australia.
Abstract
BACKGROUND AND OBJECTIVES: This study aimed to determine absolute and excess stroke risks in people with ESRD compared with the general population. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This cohort study used data linkage between the Australia and New Zealand Dialysis and Transplant Registry and hospital and death records for 10,745 people with ESRD in New South Wales from 2000 to 2010. For the general population, Australian Institute of Health and Welfare hospital usage records and Australian Bureau of Statistics census data were used. Rates and standardized incidence rate ratios of hospitalization with a stroke were calculated. RESULTS: People with ESRD had 640 hospitalizations with stroke in 49,472 person-years of follow-up (1294 per 100,000 person-years), and people in the general population had 338,392 hospitalizations with stroke (212 per 100,000 person-years), an incidence rate ratio of 3.32 (95% confidence interval, 3.31 to 3.33). Excess risk was greater for women (incidence rate ratio, 5.14; 95% confidence interval, 5.11 to 5.18) than men (incidence rate ratio, 2.52; 95% confidence interval, 2.51 to 2.54; P for interaction <0.001) and decreased with age. People ages 35-39 years old with ESRD had an 11 times increased risk of stroke (incidence rate ratio, 11.08; 95% confidence interval, 9.41 to 13.05), and risk in people ages ≥85 years old increased 2-fold (incidence rate ratio, 2.04; 95% confidence interval, 1.87 to 2.23; P for interaction <0.001). Excess risk was greater for intracerebral hemorrhage (incidence rate ratio, 4.18; 95% confidence interval, 4.11 to 4.26) than ischemic stroke (incidence rate ratio, 3.43; 95% confidence interval, 3.40 to 3.45; P for interaction <0.01). CONCLUSIONS: People with ESRD have a substantially higher risk of stroke, particularly women and young people, and hemorrhagic stroke. Future work could investigate effective and safe interventions for primary and secondary prevention of stroke in people with ESRD.
BACKGROUND AND OBJECTIVES: This study aimed to determine absolute and excess stroke risks in people with ESRD compared with the general population. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This cohort study used data linkage between the Australia and New Zealand Dialysis and Transplant Registry and hospital and death records for 10,745 people with ESRD in New South Wales from 2000 to 2010. For the general population, Australian Institute of Health and Welfare hospital usage records and Australian Bureau of Statistics census data were used. Rates and standardized incidence rate ratios of hospitalization with a stroke were calculated. RESULTS:People with ESRD had 640 hospitalizations with stroke in 49,472 person-years of follow-up (1294 per 100,000 person-years), and people in the general population had 338,392 hospitalizations with stroke (212 per 100,000 person-years), an incidence rate ratio of 3.32 (95% confidence interval, 3.31 to 3.33). Excess risk was greater for women (incidence rate ratio, 5.14; 95% confidence interval, 5.11 to 5.18) than men (incidence rate ratio, 2.52; 95% confidence interval, 2.51 to 2.54; P for interaction <0.001) and decreased with age. People ages 35-39 years old with ESRD had an 11 times increased risk of stroke (incidence rate ratio, 11.08; 95% confidence interval, 9.41 to 13.05), and risk in people ages ≥85 years old increased 2-fold (incidence rate ratio, 2.04; 95% confidence interval, 1.87 to 2.23; P for interaction <0.001). Excess risk was greater for intracerebral hemorrhage (incidence rate ratio, 4.18; 95% confidence interval, 4.11 to 4.26) than ischemic stroke (incidence rate ratio, 3.43; 95% confidence interval, 3.40 to 3.45; P for interaction <0.01). CONCLUSIONS:People with ESRD have a substantially higher risk of stroke, particularly women and young people, and hemorrhagic stroke. Future work could investigate effective and safe interventions for primary and secondary prevention of stroke in people with ESRD.
Authors: Suetonia C Palmer; Sankar D Navaneethan; Jonathan C Craig; David W Johnson; Vlado Perkovic; Sagar U Nigwekar; Jorgen Hegbrant; Giovanni F M Strippoli Journal: Cochrane Database Syst Rev Date: 2013-09-11
Authors: Stephen L Seliger; Daniel L Gillen; W T Longstreth; Bryan Kestenbaum; Catherine O Stehman-Breen Journal: Kidney Int Date: 2003-08 Impact factor: 10.612
Authors: J Craig Longenecker; Josef Coresh; Neil R Powe; Andrew S Levey; Nancy E Fink; Alice Martin; Michael J Klag Journal: J Am Soc Nephrol Date: 2002-07 Impact factor: 10.121
Authors: Suetonia C Palmer; Lucia Di Micco; Mona Razavian; Jonathan C Craig; Vlado Perkovic; Fabio Pellegrini; Meg J Jardine; Angela C Webster; Sophia Zoungas; Giovanni F M Strippoli Journal: Cochrane Database Syst Rev Date: 2013-02-28
Authors: Wei Ling Lau; Mark Fisher; Dana Greenia; David Floriolli; Evan Fletcher; Baljeet Singh; Seyed Ahmad Sajjadi; Maria M Corrada; Christina Whittle; Claudia Kawas; Annlia Paganini-Hill Journal: Neurobiol Aging Date: 2020-04-29 Impact factor: 4.673
Authors: Patrick B Mark; Pardeep S Jhund; Matthew R Walters; Mark C Petrie; Albert Power; Claire White; Michele Robertson; Eugene Connolly; Stefan D Anker; Sunil Bhandari; Kenneth Farrington; Philip A Kalra; Charles R V Tomson; David C Wheeler; Christopher G Winearls; John J V McMurray; Iain C Macdougall; Ian Ford Journal: Kidney360 Date: 2021-09-16
Authors: Amber O Molnar; Sarah E Bota; Amit X Garg; Ziv Harel; Ngan Lam; Eric McArthur; Gihad Nesrallah; Jeffrey Perl; Manish M Sood Journal: J Am Soc Nephrol Date: 2016-01-28 Impact factor: 10.121
Authors: David Collister; Jeff S Healey; David Conen; K Scott Brimble; Claudio Rigatto; Ziv Harel; Manish M Sood; Michael Walsh Journal: Can J Kidney Health Dis Date: 2019-01-08
Authors: Wei Ling Lau; Ane C F Nunes; Vitaly Vasilevko; David Floriolli; Long Lertpanit; Javad Savoj; Maria Bangash; Zhihui Yao; Krunal Shah; Sameen Naqvi; Annlia Paganini-Hill; Nosratola D Vaziri; David H Cribbs; Mark Fisher Journal: Transl Stroke Res Date: 2019-05-04 Impact factor: 6.829